Zobrazeno 1 - 9
of 9
pro vyhledávání: '"HL Ratan"'
Publikováno v:
Journal of Clinical Urology. 10:368-373
Objective: Patients at our institution with asymptomatic calyceal stones (Patients and methods: All patients satisfying the above criteria discharged during October 2009–June 2011 were reviewed for protocol compliance, symptomatic events and/or sur
Autor:
Green WJ; Department of Urology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK., Ball G; The John van Geest Cancer Research Centre, Department of Life Sciences, Nottingham Trent University, Nottingham NG11 8NS, UK., Hulman G; Department of Cellular Pathology, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK., Johnson C; The John van Geest Cancer Research Centre, Department of Life Sciences, Nottingham Trent University, Nottingham NG11 8NS, UK., Van Schalwyk G; Pathology Department, Division of Planned Care, Royal Derby Hospital, Derby DE22 3NE, UK., Ratan HL; Department of Urology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK., Soria D; Advanced Data Analysis Centre, School of Computer Science, Faculty of Science, University of Nottingham, Nottingham NG8 1BB, UK., Garibaldi JM; Advanced Data Analysis Centre, School of Computer Science, Faculty of Science, University of Nottingham, Nottingham NG8 1BB, UK., Parkinson R; Department of Urology, Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK., Hulman J; Department of Cellular Pathology, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK., Rees R; The John van Geest Cancer Research Centre, Department of Life Sciences, Nottingham Trent University, Nottingham NG11 8NS, UK., Powe DG; The John van Geest Cancer Research Centre, Department of Life Sciences, Nottingham Trent University, Nottingham NG11 8NS, UK.; Department of Cellular Pathology, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2016 Jul 12; Vol. 115 (2), pp. 236-42. Date of Electronic Publication: 2016 Jun 23.
Autor:
Onion D; Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom. University of Nottingham Flow Cytometry Facility, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom., Argent RH; Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Reece-Smith AM; Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Craze ML; Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Pineda RG; Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Clarke PA; Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Ratan HL; Department of Urology, Nottingham University NHS Trust, QMC, Nottingham, United Kingdom., Parsons SL; Nottingham University NHS Trust, City Hospital Campus, Nottingham, United Kingdom., Lobo DN; Nottingham Digestive Diseases National Institute of Health Research Biomedical Research Unit, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Duffy JP; Department of Thoracic Surgery, Nottingham University NHS Trust, City Hospital Campus, Nottingham United Kingdom., Atherton JC; Nottingham Digestive Diseases National Institute of Health Research Biomedical Research Unit, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., McKenzie AJ; Crown Bioscience UK Ltd, Hillcrest, Loughborough, United Kingdom., Kumari R; Crown Bioscience UK Ltd, Hillcrest, Loughborough, United Kingdom., King P; Janssen Research and Development, Spring House, Pennsylvania., Hall BM; Janssen Research and Development, Spring House, Pennsylvania., Grabowska AM; Ex Vivo Cancer Pharmacology Centre of Excellence, Cancer Biology, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom. anna.grabowska@nottingham.ac.uk.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2016 Apr; Vol. 15 (4), pp. 753-63. Date of Electronic Publication: 2016 Feb 12.
Autor:
Jackson BL; Unit of Cancer Biology, University of Nottingham, Queens Medical Centre, Derby Road, Nottingham NG7 2UH, England. mrbljackson@gmail.com., Grabowska A, Ratan HL
Publikováno v:
BMC cancer [BMC Cancer] 2014 Dec 10; Vol. 14, pp. 930. Date of Electronic Publication: 2014 Dec 10.
Autor:
Cutress ML; Ipswich Hospital NHS Trust, Heath Road, Ipswich, Suffolk. mcutress@doctors.org.uk, Ratan HL, Williams ST, O'Brien MF
Publikováno v:
BJU international [BJU Int] 2010 Oct; Vol. 106 (8), pp. 1130-6. Date of Electronic Publication: 2010 Aug 25.
Autor:
Ratan HL; Division of Urology, Leicester General Hospital, Leicester, UK., Gescher A, Steward WP, Mellon JK
Publikováno v:
BJU international [BJU Int] 2003 Dec; Vol. 92 (9), pp. 890-5.
Autor:
Ratan HL; Division of Urology, University of Leicester, Leicester General Hospital, Gwendolen Road, Leicester LE5 4PW, UK., Steward WP, Gescher AJ, Mellon JK
Publikováno v:
Urologic oncology [Urol Oncol] 2002 Nov-Dec; Vol. 7 (6), pp. 223-7.